Lifecycle Management Strategy Lead - Friedreich Ataxia

About This RoleTo support value creation, we established a Product Development and Commercialization (PDC) Team. Having made the first approved treatment for Friedreich Ataxia available in the US, Germany and 20 further countries to date, PDC priorities include geographic expansion and launch in collaboration with the affiliates/regions, executing a robust evidence generation plan and life-cycle management (LCM).  The role of this Lifecycle Management (LCM) Strategy Lead - Friedreich Ataxia is to work in particular across Research, Development, Regulatory, Clinical Operations, Biomarkers, Medical and Corporate Affairs functions as part of the PDC team, reporting to the PDC Lead. The LCM Strategy Lead will operate with senior leaders in each key PDC function and help to facilitate therapeutic area and asset growth in this highly matrixed environment. The role is based in Cambridge, Massachusetts, USA Headquarters.What You’ll Do Execute and evolve the disease area and asset strategy for life-cycle management, for example the development and implementation of new studies (e.g., Pediatric Study), formulations, novel biomarkers, patient management support strategies, and other drivers of near- and longer-term growth Develop a global KME management plan that expands PDC engagement for LCM feedback beyond the core group of experts the regions depend uponLead PDC strategic team to define the external communications strategy for FA, based on 360-degree view of the competitive landscape. Triage externally generated data for internal communication and guidanceDevelop compelling business cases and engage cross-functional experts to develop recommendations for PDC endorsement from executive managementDrive the Disease Area Strategic Plan and Long-Range Forecast processesWho You Are You are a leader, a strategic thinker with the energy and vision to succeed in a fast paced and complex environment. You have experience and are passionate about driving positive change for patient with rare diseases. Based on your strong expertise in either R&D, business development, commercial or corporate strategy, you are used to driving and leading cross-functional collaboration at all levels and to influence and guide senior stakeholders.